677 related articles for article (PubMed ID: 20164447)
1. Neuroprotection against retinal ischemia-reperfusion injury by blocking the angiotensin II type 1 receptor.
Fukuda K; Hirooka K; Mizote M; Nakamura T; Itano T; Shiraga F
Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3629-38. PubMed ID: 20164447
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effects of angiotensin II type 1 receptor (AT1-R) blocker via modulating AT1-R signaling and decreased extracellular glutamate levels.
Fujita T; Hirooka K; Nakamura T; Itano T; Nishiyama A; Nagai Y; Shiraga F
Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):4099-110. PubMed ID: 22661470
[TBL] [Abstract][Full Text] [Related]
3. Activation of the aldosterone/mineralocorticoid receptor system and protective effects of mineralocorticoid receptor antagonism in retinal ischemia-reperfusion injury.
Liu Y; Hirooka K; Nishiyama A; Lei B; Nakamura T; Itano T; Fujita T; Zhang J; Shiraga F
Exp Eye Res; 2012 Mar; 96(1):116-23. PubMed ID: 22200488
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effects of angiotensin II type 1 receptor blocker in a rat model of chronic glaucoma.
Yang H; Hirooka K; Fukuda K; Shiraga F
Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5800-4. PubMed ID: 19608537
[TBL] [Abstract][Full Text] [Related]
5. Expressions of inducible nitric oxide synthase and cyclooxygenase-2 in gastric ischemia-reperfusion: role of angiotensin II.
Gemici B; Tan R; Ongüt G; Izgüt-Uysal VN
J Surg Res; 2010 Jun; 161(1):126-33. PubMed ID: 19959193
[TBL] [Abstract][Full Text] [Related]
6. Protective mechanisms of the angiotensin II type 1 receptor blocker candesartan against cerebral ischemia: in-vivo and in-vitro studies.
Liu H; Kitazato KT; Uno M; Yagi K; Kanematsu Y; Tamura T; Tada Y; Kinouchi T; Nagahiro S
J Hypertens; 2008 Jul; 26(7):1435-45. PubMed ID: 18551021
[TBL] [Abstract][Full Text] [Related]
7. Deleterious role of anti-high mobility group box 1 monoclonal antibody in retinal ischemia-reperfusion injury.
Yang H; Hirooka K; Liu Y; Fujita T; Fukuda K; Nakamutra T; Itano T; Zhang J; Nishibori M; Shiraga F
Curr Eye Res; 2011 Nov; 36(11):1037-46. PubMed ID: 21999229
[TBL] [Abstract][Full Text] [Related]
8. Aliskiren reduces myocardial ischemia-reperfusion injury by a bradykinin B2 receptor- and angiotensin AT2 receptor-mediated mechanism.
Koid SS; Ziogas J; Campbell DJ
Hypertension; 2014 Apr; 63(4):768-73. PubMed ID: 24420538
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of catalase on retinal ischemia/reperfusion injury in rats.
Chen B; Tang L
Exp Eye Res; 2011 Nov; 93(5):599-606. PubMed ID: 21824472
[TBL] [Abstract][Full Text] [Related]
10. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
Nagai N; Izumi-Nagai K; Oike Y; Koto T; Satofuka S; Ozawa Y; Yamashiro K; Inoue M; Tsubota K; Umezawa K; Ishida S
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4342-50. PubMed ID: 17724226
[TBL] [Abstract][Full Text] [Related]
11. Expression and neuroprotective effect of hepatocyte growth factor in retinal ischemia-reperfusion injury.
Shibuki H; Katai N; Kuroiwa S; Kurokawa T; Arai J; Matsumoto K; Nakamura T; Yoshimura N
Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):528-36. PubMed ID: 11818401
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of pioglitazone on retinal ischemia/reperfusion injury in rats.
Zhang XY; Xiao YQ; Zhang Y; Ye W
Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):3912-21. PubMed ID: 23557740
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of angiotensin II action protects rat steatotic livers against ischemia-reperfusion injury.
Casillas-Ramirez A; Amine-Zaouali M; Massip-Salcedo M; Padrissa-Altés S; Bintanel-Morcillo M; Ramalho F; Serafín A; Rimola A; Arroyo V; Rodés J; Roselló-Catafau J; Peralta C
Crit Care Med; 2008 Apr; 36(4):1256-66. PubMed ID: 18379253
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin AT1 receptor blockers suppress ischemia/reperfusion-induced gastric injury in rats.
Nakagiri A; Sunamoto M; Murakami M
Inflammopharmacology; 2007 Aug; 15(4):171-4. PubMed ID: 17701020
[TBL] [Abstract][Full Text] [Related]
15. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin.
Nagai N; Oike Y; Izumi-Nagai K; Koto T; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Ishida S
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2321-6. PubMed ID: 17460297
[TBL] [Abstract][Full Text] [Related]
16. Flow-dependent dilation mediated by endogenous kinins requires angiotensin AT2 receptors.
Bergaya S; Hilgers RH; Meneton P; Dong Y; Bloch-Faure M; Inagami T; Alhenc-Gelas F; Lévy BI; Boulanger CM
Circ Res; 2004 Jun; 94(12):1623-9. PubMed ID: 15131008
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme inhibitor enhances liver regeneration following partial hepatectomy: involvement of bradykinin B2 and angiotensin AT1 receptors.
Yayama K; Sugiyama K; Miyagi R; Okamoto H
Biol Pharm Bull; 2007 Mar; 30(3):591-4. PubMed ID: 17329864
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effects of granulocyte colony-stimulating factor on ischemia-reperfusion injury of the retina.
Shima C; Adachi Y; Minamino K; Okigaki M; Shi M; Imai Y; Yanai S; Takahashi K; Ikehara S
Ophthalmic Res; 2012; 48(4):199-207. PubMed ID: 22868688
[TBL] [Abstract][Full Text] [Related]
19. Effects of captopril and angiotensin II receptor blockers (AT1, AT2) on myocardial ischemia-reperfusion induced infarct size.
Parlakpinar H; Ozer MK; Acet A
Cytokine; 2011 Dec; 56(3):688-94. PubMed ID: 21975128
[TBL] [Abstract][Full Text] [Related]
20. Evidence for the involvement of NADPH oxidase in ischemia/reperfusion-induced gastric damage via angiotensin II.
Nakagiri A; Sunamoto M; Takeuchi K; Murakami M
J Physiol Pharmacol; 2010 Apr; 61(2):171-9. PubMed ID: 20436217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
